Ara
Toplam kayıt 3, listelenen: 1-3
A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?
(AVES, 2015)
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese patients require dose adjustment according to ...
Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight Reply
(2016)
Under-representation of obese patients in the subgroups of relevant studies raises concerns about the efficacy and safety of new oral anticoagulants (NOACs). The number of patients with high body weights is quite low in ...
The heart of the matter: Cardiac stem cells
(Tubitak Scientific, 2016)
Cardiovascular diseases are the primary cause of death in the world. Pharmacological and surgical approaches are the main treatment options for heart disease; however, heart transplantation may be the only option for ...